Department of Otorhinolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK.
Department of Otorhinolaryngology - Head and Neck Surgery, NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, UK.
J Laryngol Otol. 2023 Jul;137(7):763-768. doi: 10.1017/S002221512200192X. Epub 2022 Aug 23.
This study aimed to investigate the use of the head and neck cancer risk calculator version 2 in a primary care setting and to evaluate the impact of the risk calculator on the number of referrals stratified by urgency and cancer yield.
Referrals between April 2019 and August 2019, April 2020 and July 2020 (pre-risk calculator) and August 2020 and July 2021 (post-risk calculator) were analysed. Referral urgency, head and neck cancer risk calculator version 2 score, cancer diagnosis, cancer type and further investigations were recorded.
The 2023 patient encounters were analysed; there were 1110 (55 per cent) referrals before head and neck cancer risk calculator version 2 use and 913 (45 per cent) after head and neck cancer risk calculator version 2 use. A higher proportion of older ( 0.001) and male ( 0.013) patients were seen post-head and neck cancer risk calculator version 2 use. All cancer cases were seen on the urgent suspicion of cancer pathway post-head and neck cancer risk calculator version 2 use; however, a higher proportion of patients were seen as urgent suspicion of cancer (51.1 83.5 per cent; 0.001). Overall, the cancer diagnosis rate increased from 2.7 to 4.1 per cent.
The head and neck cancer risk calculator version 2 had high sensitivity in cancer diagnosis. More studies are required to optimise the predicted versus actual cancer probability gap.
本研究旨在探讨头颈部癌症风险计算器版本 2 在初级保健环境中的应用,并评估风险计算器对按紧急程度和癌症检出率分层的转诊数量的影响。
分析了 2019 年 4 月至 2019 年 8 月、2020 年 4 月至 2020 年 7 月(风险计算器使用前)和 2020 年 8 月至 2021 年 7 月(风险计算器使用后)的转诊情况。记录了转诊的紧急程度、头颈部癌症风险计算器版本 2 评分、癌症诊断、癌症类型和进一步检查。
分析了 2023 名患者的就诊情况;在使用头颈部癌症风险计算器版本 2 之前有 1110 例(55%)转诊,在使用头颈部癌症风险计算器版本 2 之后有 913 例(45%)。使用头颈部癌症风险计算器版本 2 后,更多的是年龄较大( 0.001)和男性( 0.013)患者。所有癌症病例均在使用头颈部癌症风险计算器版本 2 后通过癌症可疑紧急路径就诊;然而,更多的患者被视为癌症可疑紧急(51.1 83.5%; 0.001)。总体而言,癌症诊断率从 2.7%增加到 4.1%。
头颈部癌症风险计算器版本 2 在癌症诊断方面具有较高的灵敏度。需要进一步研究以优化预测与实际癌症概率差距。